Incannex Secures US Patent for Sleep Apnea Drug Candidate IHL-42X

Дата публикации: 16-07-2026 02:04:41

The granted patent protects the proprietary oral combination therapy through at least 2040, as the company prepares to launch its Phase 2 dose optimization study.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Nexalin Technology Secures US Patent for Deep-Brain Stimulation Targeting Insomnia	5	7	29-06-2026
2	Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision	0	5	22-06-2026
3	Alkermes Granted Orphan Drug Designations for Alixorexton in US, Europe	0	5	16-06-2026
4	Eli Lilly Completes Acquisition of Centessa Pharmaceuticals to Advance Narcolepsy Treatments	2	6	24-06-2026
5	Health Canada Approves Zepbound for OSA in Adults With Obesity	5	8	25-06-2026
6	Lilly’s Investigational Triple Agonist Retatrutide Reduces OSA Severity in Phase 3 Trial	6	7	23-06-2026
7	New Pivotal Study Data Released for Takeda’s Oveporexton	5	7	16-06-2026
8	Ognomy Sleep Secures $20M Series A to Expand AI-Enabled Sleep Apnea Care	5	7	01-07-2026
9	Bryggs Medical Launches ULTepap 2 with Adjustable Pressure Settings	0	5	06-07-2026
10	OxiWear Secures Payor Coverage for Continuous Oxygen Measuring Wearable	5	7	19-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: sleepreviewmag.com.